Related Experiment Video
Updated: Oct 20, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Dynamic Properties of the Intestinal Ecosystem Call for Combination Therapies, Targeting Inflammation and Microbiota,
Maarten van de Guchte1, Stanislas Mondot1, Joël Doré2
1University Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
The intestinal ecosystem may exist in alternative stable states, potentially blocking remission in ulcerative colitis (UC) patients. Combining inflammation suppression with microbiota management is crucial for effective UC treatment.
Area of Science:
- Investigates the complex dynamics of the intestinal ecosystem and its impact on human health.
- Focuses on the interplay between gut microbiota and host inflammatory responses.
Background:
- Intestinal microbiota-host interactions are critical in health and disease, with dysbiosis linked to immune-mediated conditions.
- Understanding intestinal ecosystem dynamics is key for effective disease treatment.
- A novel hypothesis suggests health and disease represent alternative stable states of the intestinal ecosystem.
Purpose of the Study:
- To determine if alternative stable states exist within the intestinal ecosystem.
- To investigate the potential role of these states in ulcerative colitis (UC) remission.
Main Methods:
- Analysis of pediatric UC patient data, including stool samples collected over one year.
- Microbiota status assessed via 16S ribosomal RNA gene sequencing.
- Host inflammatory status measured by fecal calprotectin levels.
Main Results:
- Identification of four distinct microbiota states and four host states.
- Longitudinal data indicate that improvements in host inflammation correlate with microbiota improvements.
- Evidence suggests that alternative states act as barriers, hindering or blocking these improvements.
Conclusions:
- The intestinal ecosystem can exist in alternative stable states, impacting UC remission.
- Inflammation suppression strategies for UC should be integrated with microbiota management for enhanced treatment efficacy.
More Related Videos
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

